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ABSTRACT

Two strains of White Leghom hens selected for high (HA) or low (LA)
antibody response to challenge with sheep red blood cells were used to determine
differences in circulating levels of progesterone (P4) and luteinizing hormone
(LH), and to determine in vitro effects of tumor necrosis factor alpha (TNF a) on
granulosa cell steroid secretion during different periods of the estrous cycle. In
experiment one, hens were serially bled from 4 hours after oviposition until the
next oviposition.

Plasma was analyzed for P4 and LH using validated

radioimmunoassays (RIA's). In the second experiment, hens were sacrificed at 16
and 37 weeks of egg production. Granulosa cells isolated from the F 1, F2, and F3
follicles were incubated for 3 hours in the presence of; 1) untreated RPMI 1640 +
0.1% bovine serum albumin + 1% antibiotics (control) 2) 5 ng/ml human
recombinant TNFa (hTNFa) 3) 5 ng/ml murine recombinant TNFa (mTNFa) 4)
100 ng/ml ovine LH (oLH) 5) hTNFa plus oLH 6) mTNFa plus oLH.
Conditioned media was analyzed for P4 and P5 secretion as before.
Plasma levels of both P4 and LH were significantly higher (P~0.05) among
HA hens during the peak preovulatory period of the estrous cycle (-6 to -1 hours
before oviposition). Circulating levels of P4 were 1.45, 2.19, 2.67, 2.66, and 2.38
ng/ml in LA hens versus 1.82, 3.05, 3.19, 3.07, 3.01, and 2.79 ng/ml respectively
in HA hens at 6, 5, 4, 3, 2, and 1 hour prior to oviposition. Levels of LH were
2.36, 3.36, 3.57, 2.81, 2.41, and 1.95 ng/ml in LA hens versus 3.58, 5.27, 5.38,
4.51, 3.77, and 3.71 ng/ml respectively in HA hens for the same period.
As with plasma, granulosa cells from HA hens produced more (P~0.05) P4
and P5 than did those from LA hens.

Similarly, granulosa cells from larger

follicles secreted more (P~0.05) P4 and P5 than did those from smaller follicles.
Treatment of granulosa cells with human, but not murine, TNFa reduced (P~0.05)
Vll

basal P4 and P 5 production by granulosa cells from preovulatory follicles.
Conversely, treatment of cells with oLH significantly increased (P~0.05) P 4 and P 5
as compared to controls. The combination of mTNFa., but not h1NFa., and oLH
consistently stimulated (P~0.05) P4 and P 5 secretion above that observed with
treatment of oLH alone. Mouse 1NFa. is known to activate both type I and type II
1NFa. receptors, while h1NFa. binds only the type I receptor. This may explain
the differential effects on in vitro steroid secretion observed through use of the two
forms of 1NFa. in these experiments. Furthermore, the observation that h1NFa.
and oLH rarely caused significant increases, but frequently caused numerical
increases in P 4 and P 5 secretion is suggestive of a ligand passing role for the type II
receptor. No clear pattern emerged as to when during the estrous cycle h1NFa.
affected steroid production. In the avian, reduced steroidogenic capacity
(specifically, the production of progesterone) can lead to delayed or inhibited
ovulation.

Results from these experiments suggest a potential role for human

and/or murine 1NFa. in reproduction in the laying hen (Gallus domesticus).

Vlll

1. LITERATURE REVIEW

Cytokines are a group of 6,000 - 60,000 kiloDalton (kDa) proteins, of
which over thirty have been isolated since their discovery in the early
1970's (Rafael and Orvieto, 1992).

These proteins are derived from

activated immune cells and are involved in cell-to-cell communication,
resulting in initiation of the immune response, inflammatory reactions, and
hematopoiesis (Dinarello and Mier, 1987). These pleiotropic peptides are
also

potent regulatory factors.

Unlike hormones, which are usually

produced at a specific locus and act systemically, cytokines are produced by
a wide variety of cells and act in an autocrine, paracrine, or endocrine
fashion (Klasing and Johnstone, 1991).

Cytokines can be further

subgrouped into interleukins, lymphokines, and monokines.

The term

interleukin refers to soluble factors which mediate communication between
leukocytes, while lymphokines and monokines designate cytokines which
are produced by lymphocyte and monocyte/macrophage cells respectively
(Rafael and Orvieto, 1992). As more information is compiled concerning
their source and function, it is apparent that many cytokines fall into more
than one of these subgroupings.
1

Tumor necrosis factor alpha (TNFa) is a potent monokine that was
discovered in 1975 in an attempt to identify a protein involved in tumor
cytotoxicity (Carswell et al., 1975). TNFa is also referred to as "cachectin"
for its involvement in the phenomenon of wasting, and "necrosin" for its
ability to cause cell death (Beutler and Cerami, 1986). TNFa is classified
as a type II membrane protein which is characterized by a C-terminus in the
extracellular domain.

Other type II membrane proteins include; TNFP

(lymphotoxin), Fas ligand, OX40 ligand, Chain of Differentiation (CD) 40
ligand, CD27 ligand, CD30 ligand, and lymphotoxin

p (Gruss and Dower,

1995). Structurally, TNFa is a 26 kDa membrane bound protein which has
a 29 amino acid (aa) cytoplasmic tail, a 28 aa transmembrane region, and a
176 aa extracellular domain (Gruss and Dower, 1995). Proteolytic cleavage
of the membrane bound protein by TNFa converting enzyme (TACE)
results in the release of a 17.4 kDa, 157 aa soluble protein as a homotrimer
with a three dimensional structure similar to the "jelly roll" motif shared by
various viral capsids (Kreigler et al., 1988; Brannstrom et al., 1993; Black

et al., 1997). 1NFa. is expressed by many cell types including macrophage,
CD4+ and CD8+ thymocyte (T) cells, keratinocytes, adipocytes, kidney
tubule epithelial cells, splenocytes, astrocytes, pancreatic P-cells, neurons,
2

and osteoblasts (Hunt et al., 1992; Ware et al., 1992; Lee et al., 1993;
Yamada et al., 1993; Kern et al., 1995; Lisby et al., 1995; Modrowski et
al., 1995; Villarroya et al.,1997). Due to the wide variety of cells which
express TNFcx, it is more practical to list those cell types in which this
cytokine is not expressed or has yet to be identified.

These include

erythrocytes and resting T cells which do not express the protein nor its
receptors (Fiers, 1991). Both human and mouse TNFcx have been cloned
and exhibit approximately 79% amino acid sequence homology (Fransen et
al., 1985; Pennica et al., 1985).

Experimental evidence suggests that

normal circulating levels of TNFcx are between 10 and 80 pg/ml
(Steinshamn et al., 1995; Spengler et al., 1996). Beutler et al. (1985)
determined the half-life of TNFcx in plasma to be approximately six
minutes.
To date, two TNF ex receptors have been identified, type I and type II.
Both receptors belong to the TNFcx/nerve growth factor receptor (NGFR)
superfamily and share 28% sequence homology in their extracellular
domains (Tartaglia et al., 1993).

Their intracellular domains, however,

apparently share no sequence homology, suggesting the use of different
signaling pathways (Lewis et al., 1991 ). The TNF ex receptors are classified
3

as type I membrane proteins characterized by 4 cysteine-rich motifs in the
extracellular binding domain (Baker and Reddy, 1996). Both receptors can
be released as soluble proteins, via proteolytic cleavage of their extracellular
domains. Soluble receptors have been identified in the serum and urine of
normal and diseased patients (Spengler et al., 1996; Olsson et al., 1989).
Physiologically, soluble receptors may act to inhibit 1NFa. activity, as
cleavage of the extracellular domain reduces the number of cell surface
receptors. Soluble receptors may also bind to soluble 1NFa., thereby further
reducing concentrations of the cytokine available for receptor binding at the
cell surface.
The type I TNFa. receptor has a molecular weight of 55 kDa, and is
designated TNF-Rl, 1NF-R55, p55, or CD120a (Fiers,1991).

This

glycoprotein, consisting of a 190 aa extracellular region, a 25 aa
transmembrane segment, and a 220 aa cytoplasmic domain, binds to the
human and murine forms of TNFa. with equal affinities (Gruss and Dower,
1995; Lewis et al., 1991). Studies utilizing monoclonal and polyclonal
antibodies directed against TNF-Rl identify it as the receptor responsible
for the majority of actions associated with TNFa.. These studies implicate
the type I receptor in cytotoxicity, fibroblast proliferation, resistance to
4

Chlamydia trachomatis, antiviral activity, and synthesis of prostaglandin E2
(Englemann et al., 1990; Espevik et al., 1990; Shalaby et al., 1990; Wong et
al., 1992).

Tartaglia et al. (1993) identified a region of approximately 80

aa's within the intracellular domain of the type I receptor that is responsible
for initiating the signal for cytotoxicity.
The type II TNFa receptor has a molecular weight of 75 kDa and is
referred to as TNF-R2, TNF-R75, p75, or CD120b (Fiers, 1991). This
glycoprotein consists of a 240 aa extracellular domain, a 27 aa
transmembrane segment, and a 173 aa cytoplasmic domain (Gruss and
Dower, 1995). The larger, type II receptor exhibits a 5 fold greater affinity
for TNFa than does the type I receptor (Barbara et al., 1994). Unlike TNFRl which binds to both human and murine TNFa, the type II receptor binds
only to murine TNFa (Lewis et al., 1991). Monoclonal and polyclonal
antibody studies reveal that activation of this receptor stimulates
proliferation of primary thymocytes and cytotoxic T-cells (Sheehan et al.,
1995; Tartaglia et al., 1991).
Biological effects of TNFa on various cells and tissues have been
studied extensively. TNFa blocks the synthesis of triglycerides while
concurrently stimulating adipocytes to release current stores into the plasma,
5

thus implicating TNF a in the phenomenon known as "wasting" (Beutler and
Cerami, 1988). Complicating this already dangerous pathological state,
TNF a activates osteoclasts causing the subsequent resorption of bone

(Bertolini et al., 1986). Furthermore, Garrett et al. (1987) showed that
TNFa inhibited cartilage synthesis while promoting proteoglycan break-

down.
In addition to its involvement in cachexia, TNFa is thought to be
responsible for many of the symptoms which accompany endotoxic shock,
including; fever, hypotension, diarrhea, metabolic acidosis, and in severe
cases, death (Beutler and Cerami, 1986). TNFa has also been observed to
cause fever by inducing hypothalamic neurons to produce prostaglandin E2
(PGE2) (Dinarello et al., 1986).
However, TNFa is best known for its involvement in the
inflammatory reaction of the immune response. TNF a enhances immune
responses via activation of neutrophils and eosinophils (Silberstein et al.,
1986). Neutrophil adhesion, phagocytosis, and complement receptors are
reportedly increased upon exposure to TNFa (Shalaby et al., 1985;
Klebanoff et al., 1986; Berger et al., 1988). The proposal that ovulation is

6

akin to an inflammatory reaction suggests the possibility that cytokines may
play a role in reproductive function (Espey, 1980).
Several studies have indicated the presence ofTNFa within the ovary
of various species. Using immunocytochemistry, immunoreactive TNFa
has been localized in oocyte, granulosa, and mononuclear cells within the
ovaries of the mouse and rat (Chen et al., 1993; Marcinkiewicz et al., 1994;
Roby and Terranova, 1989). In humans, immunoreactive TNFa has been
identified in granulosa, luteal, and paraluteal cells of the ovary (Roby et al.,
1990). Evidence also exists for biologically active TNFa in cumulus cells
of the oocyte in the human, as well as follicular fluid in the human and
bovine (Zolti et al., 1990; Zolti et al., 1991; Wang et al., 1992; Jasper and
Norman, 1995). Naylor et al. (1990; 1993) determined the presence of
TNF a mRNA in human thecal cells via in situ techniques. In the corpus
luteum, TNFa has been identified in endothelial cells and large luteal cells
of swine (Hehnke-Vagnoni et al., 1995; Wuttke et al., 1993). Similarly,
TNFa has been identified in the corpus luteum of the rabbit, sheep, and cow
(Bavangados et al., 1988; 1990; Ji et al., 1991; Shaw and Britt, 1995).
Although the presence of TNF a in these tissues is readily accepted,
its origin remains to be elucidated. Bagavandoss et al. (1990) proposed that
7

the pnmary source of TNFa was from extraovarian white blood cells
infiltrating the ovary; while others suggest that TNFa may be derived from
cells resident in the ovary itself (Sancho-Tello et al., 1992). The findings by
Zolti et al. (1990) that human granulosa cells are both a source and target
for TNFa lend credence to the theory that there is an intraovarian source of
TNFa, and that it may play a role in the reproductive cycle.

In the growing mammalian follicle, granulosa cells are responsible for
the production of estrogen, as well as a small amount of progesterone. In
several studies, TNF a has been shown to suppress either aromatase or
estradiol production by granulosa cells. Emoto and Baird (1988) reported
that in cultured rat granulosa cells, 10 pg/ml - 1Ong/ml TNFa suppressed
aromatase activity in the presence of 250 ng/ml follicle stimulating hormone
(FSH). This dose-dependent response culminated in the total abolition of
FSH induced aromatase activity at 10 ng/ml TNF a. A time-course study
revealed that TNFa did not inhibit the activity of the existing enzyme, but
rather, blocked any subsequent induction of aromatase activity by FSH.
Similarly, Adashi et al. (1990) showed a significant reduction in FSH
induced estradiol production in rat granulosa cells (10 ng/ml TNFa). In
small human and bovine follicles, TNFa inhibited FSH induced aromatase
8

activity and estradiol production by granulosa cells (Montgomery et al.,
1996; Spicer and Alpizar, 1994). Furthermore, TNFa (0.1-100 ng/ml) was
shown to reduce FSH induced LH receptor formation in cultured rat
granulosa cells, with an almost complete inhibition at 50 ng/ml (Darbon et
al., 1989). Taken together, these findings suggest a possible role for TNFa
in modulation of granulosa cell differentiation.
In response to an LH surge, mammalian granulosa cells luteinize to
become granulosa-luteal cells, and eventually, either small or large luteal
cells of the corpus luteum. These cells are responsible for the increased
progesterone production associated with the luteal phase of the estrous cycle
and pregnancy. Adashi et al. (1990) reported that TNFa (10 ng/ml) caused
significant inhibition of FSH stimulated (100 ng/ml) progesterone
production in granulosa-luteal cells of the rat.

Similarly, TNFa caused

decreased production of progesterone in response to LH, oxytocin, and
forskolin in the small luteal cells of swine (Richards and Almonds, 1994;
Wuttke et al., 1993).

1NFa reportedly increased the production of

prostaglandins, specifically PGF 2a, in luteal cells of the human and bovine,
as well as in luteinized granulosa luteal cells in the human (Wang et al.,
1992; Zolti et al. 1990; Benyo and Pate, 1992). The ability of TNFa to
9

inhibit gonadotropin induced progesterone production, while stimulating
that of prostaglandins, suggests a luteotlytic role for the cytokine (Pate,
1995).
In mammals, the granulosa cell layer is responsible for the
production of estrogens, whereas the theca layer contains androgen and
progesterone producing cells. Roby and Terranova ( 1990) found that basal
and FSH induced progesterone were inhibited by TNFa in rat granulosaluteal cells, however, in cultured whole follicles (theca included) under the
same conditions, progesterone production was actually increased by TNFa.,
with a concurrent increase in androgen production by the theca cells (Roby
and Terranova, 1990). This implies the possibility that the effects of TNFa.
on steroid production in isolated granulosa cells may be very different from
its effects on granulosa cells co-cultured with theca cells. Conversely, in
the rat, TNF a caused a dose-dependent inhibition of human chorionic
gonadotropin-stimulated androsterone and androstenedione production in
whole ovarian dispersates (Andreani et al., 1991; Zachow et al., 1992). In
theca cells of the pig, TNFa. caused a dose-dependent inhibition of LH
stimulated progesterone at concentrations of between 0.1 and 100 ng/ml
(Tekpetey et al., 1993). Interestingly, TNFa. has been shown to induce
10

clustering of theca-interstitial cells of the rat (Zachow et al., 1992). It has
therefore been suggested that TNF a may play some role in the early
organization of follicular cells (granulosa and/or theca) around the oocyte
(Terranova et al., 1995).
While the effects of TNFa on ovarian steroidogenesis may be
apparent, the mechanism(s) by which they are brought about are not.
Adashi et al. (1989) ruled out the possibility that the inhibitive action of
TNFa on granulosa cell steroidogenesis is a lasting nonspecific effect due

to its cytotoxicity. TNFa does not significantly reduce cell number, DNA
content, or viability, and the effects of TNFa are reversed upon removal of
the cytokine (Adashi et al., 1989). These data suggested that TNFa directly
and specifically regulates steroidogenesis. Luteinizing hormone receptor
numbers are reportedly reduced by TNFa in the follicular cells of the rat
(Darbon et al., 1989). Tumor necrosis factor a. has been reported to inhibit
LH induced cAMP accumulation in theca and granulosa cells of the pig and
rat (Tekpetey et al., 1993; Veldhuis et al., 1991; Zachow et al., 1992; Emoto
and Baird, 1988).

Zachow et al. ( 1993) found that in addition to LH

receptors and cAMP, TNF a directly inhibited protein kinase A. Tumor
necrosis factor a also inhibited the activities of P450 side chain cleavage
11

(P4soscc) and 3 f3-hydroxysteroid dehydrogenase enzymes, as well as the
expression of cytochrome P4soscc mRNA in swine (Veldhuis et al. 1991 ).
Logically, one might assume the TNFa has the same effect on ovarian
steroidogenesis in the avian as that in the mammal. However, the avian
ovary differs from mammalian ovaries in a number of important ways.
Initially, both left and right ovaries and oviducts are present in embryonic
hens. However, shortly after hatching, the right ovary regresses in response
to an unknown factor( s) secreted by the left ovary (Marrone and Hertendy,
1983 ). The majority of follicles on the ovary of the hen are small white or
small yellow follicles (SWF's or SYF's) with diameters between 1 and 8
millimeters (mm; Armstrong, 1985). The larger (>8mm diameter), yolkfilled follicles, which are attached to the ovary by follicular stalks, are
arranged in a hierarchy based on size (Bahr and Nalbanov, 1977). The
largest of these five or six pre-ovulatory follicles (F 1, F2, ••• F6) will be the
next to ovulate (Gilbert, 1971). When the largest follicle (F 1) ovulates, the
former F2 follicle moves up in the hierarchy (becoming the F 1 follicle), as do
all other pre-ovulatory follicles. Unlike mammals, there is no corpus luteum
(CL) formation following ovulation in the hen.

However, the biggest

difference is that granulosa cell progesterone is the predominant hormone
12

driving the avian cycle, rather than estrogen as in the mammal.

These

differences suggest that the role played by TNFa in reproductive function
(if any) may be quite different for avian species.
As the follicle matures, the great increase in size is accompanied by
changes in steroidogenic function.

Small white follicles are the major

source of estrogen in the hen (Armstrong, 1984). While the largest preovulatory follicle (F 1) is known to be responsible for the majority of
progesterone produced in the hen ovary, some contribution is made by the
smaller pre-ovulatory follicles (Fi-F 4 ; Huang et al., 1979).

These

differences are due to changes in granulosa and theca cell physiology as the
follicle matures.
Each follicle on an avian ovary consists primarily of two cell layers.
The innermost layer made up of granulosa cells which surround the yolk
and ovum of the follicle. The theca layer, which is highly vascularized and
innervated, is located immediately outside and adjacent to the granulosa
layer (Hodges, 1974). The two layers are, however, physically separated by
the basement membrane.

As stated previously, small follicles are

responsible for the majority of estrogen produced in the ovary.

This

estrogen is produced solely by the theca layer, as the granulosa cells of
13

small follicles are steroidogenically incompetent (Davidson et al., 1979).
The inability of granulosa cells from small follicles to produce steroids is
due to the inactivity of the 17a.-hydroxylase and C 17,20 lyase enzymes
(Tilly et al., 1991). When the follicle reaches 2 - 4 mm in diameter, the
theca layer differentiates into theca intema and theca extema cells (Nitta et
al., 1991). As the follicle approaches ovulation, enzyme activity (aromatase

and 3f3-hydroxy-~5-steroid dehydrogenase) in the theca layer decreases,
culminating in the complete cessation of steroidogenic capacity in the theca
cells of F 1 follicles (Huang et al., 1979; Armstrong, 1982). It is not until the
follicle reaches 9 - 12 mm in diameter that its granulosa cells are capable of
producing progesterone. Furthermore, although LH receptors are present on
smaller follicles, granulosa cells will not respond to LH until the follicle is
12 - 15 mm in diameter (Tilly et al., 1991).
Currently, there are two theories that have been proposed to describe
the steroidogenic events that take place in the avian ovary. Huang et al.
( 1979) proposed a two-cell model of follicular steroidogenesis which
assumes that the theca layer is uniform in its steroidogenic function. This
theory proposes that the majority of progestin production, as well as a small
amount of androgen synthesis, is derived from the granulosa cells of pre14

ovulatory follicles.

Progestins are secreted by granulosa cells and then

further metabolized to androgens and estrogens in theca cells (Huang et al.,
1979). The more recent, three-cell theory of avian steroidogenesis proposes
that progesterone produced in granulosa cells is metabolized by two distinct
theca cell types (Porter et al., 1989). In this model, theca intema cells
utilize progesterone derived from granulosa cells to produce androgens,
which are then passed to theca extema and converted to estrogens (Porter et
al., 1989).

There has been very little research directed at the role of

cytokines on reproduction in avians.

Bryan et al. ( 1997) reported that

human recombinant TNF a at a dose of 5 ng/ml consistently inhibited in
vitro progesterone production among granulosa cells in the F 1, F2 , and F3 (3

largest) follicles of the hen.
Advances in the field of genetics have given researchers new tools to
aid in the study of reproductive function in the avian. Gross (1979) and
Siegel and Gross (1980) developed two genetic lines of White Leghorn
chickens selected for their ability to respond to an immune challenge after
an injection of sheep red blood cells (SRBC). Birds in which high levels of
antibodies were persistent five days after SRBC injection were termed high
antibody (HA), while those with low levels were called low antibody (LA).
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Using these two distinct lines, research has been conducted to determine
whether the degree of antibody production effects the ability of a bird to
resist bacterial and viral challenges. Both Hall et al. ( 1978) and Gross et al.
(1980) found that the LA line exhibited a greater susceptibility to infection
by Mycoplasma gallisepticum, coccidiosis, splenomeglia virus, New Castle
Disease, and the northern fowl mite than did the HA line. Susceptibility to

Esherichia coli and Staphylococcus aureus infection, however, was
significantly greater in the HA line (Dunnington et al., 1991 and Gross et

al., 1980). Gross et al. ( 1980) reported a 58% incidence of E. coli in the
HA line compared to 3 5% for the LA line after inoculation of the posterior
air sac with 10·3 to 10-4 cells. Similar results were reported in mice selected
for low and high antibody response to SRBC (Biozzi et al., 1979). These
results suggest that strong antibody response is negatively correlated with
the ability to defend against bacterial infection. The mechanisms by which
birds defend themselves against invasion and infection may determine
degree of resistance or susceptibility to specific diseases.
Differences in egg production characteristics between the LA and HA
lines have also been reported. Siegel et al. (1982) found that hen-day egg
production to 300 days was significantly lower in the HA line as compared
16

to the LA line. LA birds began egg production at an earlier age and at lower
body weights than did HA birds (Siegel et al., 1982 and Martin et al., 1990).
Martin et. al. (1990) reported higher body weights for LA birds as measured
at 4 and 24 weeks of age. Fertility was also different between the two lines
with HA birds exhibiting reduced fertility at all ages (Seigel et. al., 1982).
The differences in weight gain, egg production, age of sexual
maturity, and response to an immune challenge in these two lines imply that
immuno-competence and reproductive function may somehow be related.
The objectives of the following study were to: 1) determine the differences
in plasma levels of P4 and LH between HA and LA hens, 2) determine the
effect of human versus murine TNFa. on granulosa cell P4 and P5 secretion
among HA and LA lines of hens, and 3) determine the differences in P4 and
P5 production by granulosa cells during the ovulatory cycle as affected by
human and murine TNF a. in the presence of an ovulatory amount of ovine
LH.

By studying these parameters, it may be possible to gain a better

understanding of the relationship between immune status and reproductive
function in the domestic laying hen (Gallus domesticus ).
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2. MATERIALS AND METHODS

One hundred and twenty Single Comb White Leghorn hens selected
for a high (HA) or low antibody (LA) response to immuno-challenge with
sheep red blood cells (SRBC) were housed in individual cages at Cherokee
Poultry Farm, University of Tennessee at Knoxville. Hens were allowed ad
libitum access to feed and water on a lighting schedule consisting of 16
hours of light and 8 hours of darkness.

Hens were fed a standard

commercial poultry layer mash which contained 16% protein (Tennessee
Farmers CO-OP, Lavergne, TN). Egg records were maintained from hatch
to 442 days of age and were updated daily in order to determine hen-day
egg production (HDEP). Percent HDEP was defined as the percentage of
eggs laid (egg production) in a given time period per number of live hens
during that same period (hen-days; North, 1978). For example, if 4 hens
produced 9 eggs in 3 days and none died, percent HDEP for the hens in
those 3 days was 75% (9 eggs/(4hens)(3days) X 100 = 75). Data collection
began when flock HDEP reached 15% for each line. Experiment 1 was
conducted to determine in vivo levels of circulating steroids in HA and LA
hens during one ovulatory cycle. A second experiment was conducted to
18

determine in vitro steroid production of granulosa cells from HA and LA
hens as affected by 1NFex..
Experiment 1

At 14 and 34 weeks of egg production, hens were monitored for time
of oviposition and serially bled via brachia! vein cannulation as described
by Johnson (1981) at 4, 8, 12, and 16 hours after oviposition, and
subsequently every hour until the next oviposition.

This timeline was

reversed in order to reflect hours before oviposition. Three mis of blood
was collected from each hen and centrifuged at 400 X g for 10 minutes in
order to separate plasma from erythrocytes. Plasma was decanted into 12 x
75 mm borosilicate glass tubes (Fisher Scientific, Pittsburgh, PA)
containing 50 ul saturated sodium citrate (Baxter, McGraw Park, IL) and
stored at -20°C for later analysis. Hematocrits were determined every 3rd
sample to ensure that packed cell volume did not drop more than 20%
below baseline, which was determined at the time the cannula was seated.
Erythrocytes were kept separate by hen, pooled, and combined with an
equal volume of 0.9% saline and 50,000 U penicillin G (Sigma, St. Louis,
MO). Erythrocytes were returned to the hen after every 3rd blood sample to
maintain blood volume. Plasma was analyzed for progesterone (P4) using
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a validated (Bryan et. al., 1997) commercially available radioimmunoassay
kit (Diagnostic Products Corp., Los Angeles, CA). Luteinizing hormone
(LH) was measured by radioimmunoassay using specific antisera to
chicken LH (USDA-AcLH-5), reference standards (USDA-cLH-K-3), and
immuno-chemical grade hormone for radioiodination (USDA-cLH-I-3)
according to the procedure of Johnson and van Tienhoven (1980).
Experiment 2

At 16 and 37 weeks of egg production, 5 birds from each line were
sacrificed at 4, 12, 18, 24 hours post oviposition of a mid sequence egg.
The ovary was removed from each hen, washed in Hank's basal salt
solution (Gibco, Grand Island, N.Y.), 70% ethyl alcohol, and again in
Hank's before storage in RPMI-1640 on ice. Ovaries were blotted dry and
weighed. Follicles were measured (mm diameter), counted, and sorted by
size (F 1, F2, F3, 10-12 mm, 7-9 mm, 4-6 mm, and 1-3 mm).

Atretic

follicles, determined as those deflated or in a hemorrhaged state (Tilly et.
al. 1991 ), were also counted.

Upon removal of connective tissue and

vasculature surrounding the three largest follicles (F 1, F2, and F3), the
granulosa layer was microdissected from the theca layer using aseptic
techniques. Granulosa layers from the three largest follicles of each hen
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were pooled according to size, and individual cells isolated via digestion in
a 2.5 mg/ml trypsin (Sigma, St. Louis , MO)/Hank's basal salt solution
under constant agitation for 3 minutes at 37°C.

Granulosa cells were

centrifuged at 400 X g for 4 minutes and washed twice with RPMI-1640
(Gibco, Grand Island, NY).

Cells were counted by trypan blue dye

exclusion and plated at a concentration of 500,000 cells/0.5 ml in RPMI1640 media, antibiotics (50 U penicillin, 50 ng/ml streptomycin, and 100
ng/ml neomycin), and 0.1 % bovine serum albumin (Sigma, St. Louis,
MO; hereafter called complete media).

Treatments consisted of; 1)

untreated media (control), 2) 5 ng/ml human recombinant TNFa (hTNFa;
R&D Systems, Minneapolis, MN), 3) 5 ng/ml murine recombinant TNFa
(mTNFa; R&D Systems), 4) 100 ng/ml ovine LH (oLH; National Institute
of Arthritis, Diabetes and Digestive and Kidney Diseases, Bethesda, MD),
5) hTNFa + oLH, or 6) mTNFa + oLH.

Cells and their respective

treatments were cultured for 3 hours in 95% air and 5% CO2 at 39.5 °C.
After incubation, cells were pelletted, the supernatant removed and stored
in 12 x 75 borosilicate glass tubes at -20 °C for later analysis. Progesterone
(P4) secretion by granulosa cells was measured using the commercial RIA
described previously (Bryan et al., 1997). Pregnenolone (P5) secretion by
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granulosa cells was measured via radioimmunoassay and validated using
antisera to pregnenolone-3 hemisuccinate (Accurate Chemical and
Scientific Corp., Westbury, NY) and radio labeled 7-3H(N) pregnenolone
(21.0 Ci/mmol; New England Nuclear, Boston, MA). The antiserum is
known to cross-react with 17-hydroxypregnenolone ( 1.0%), progesterone
(3.0%), 17-hydroxy-progesterone (1.4%), corticosterone (<0.4%), 11deoxycorticosterone (<0.3%), cortisol (<0.3%), 11-deoxycortisol (<0.3%),
5~-pregnan-3,20 dione (<0.4%), 5a-pregnan-3,20 dione (4.5%), 5apregnan-3a01,20 one (5.6%), 5a-pregnan-3a,20a diol (<0.45%), and 5apregnan-3 ~,20 diol (<0.4%; Accurate Scientific and Chemical Corp.,
Westbury, NY). Reagents were diluted in 0.05 M sodium phosphate buffer
containing 0.1 % gelatin and 0.2% sodium azide, pH 7.4 (hereafter call
reaction buffer). Into 12 x 75 mm glass borosilicate tubes were added 400
µl reaction buffer, 100 µl antiserum (1:23,000 dilution), 100 µl 3H-P 5
(10,000 cpm), and 100 µl standard or unknown. Standards (15.625 pg/ml 4.0 ng/ml) were made by adding specific quantities of 5-pregnen-3 ~-ol-20one (Steraloids Inc., Newport, RI) to reaction buffer. Reaction mixtures
were incubated for 30 minutes at 37°C, and then for 16 hours at 4°C. After
incubation, 500 µls of

1: 10 Dextran-T70/Norit A (Fisher Scientific,
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Pittsburgh, PA) charcoal solution was added to each sample tube. Samples
were held at 4°C for 10 minutes, and then centrifuged at 1,500 X g and 4°C
(Beckman TJ-6; Fullerton, CA) for 15 minutes.

Supematants were

decanted into 50 x 16 mm scintillation vials (Sarstedt, Newton, NC), mixed
with 5 mls UltimaGold™ scintillation fluid (Packard, Downers Grove, IL),
and counted in a liquid scintillation counter (Beckman LS5801, Fullerton,
CA). Tests for parallelism were conducted using 35, 45, and 55 ul of
media pooled from the 3 largest preovulatory follicles (Table 1).

The

optimal dilution of pregnenolone antiserum was determined to be 1/23,000
which agreed with the dilution suggested by the manufacturer (Table 2).
Intra- and Inter-assay coefficients of variation for the assays were 5 .2 and
11.6%, and 7.7 and 8.9% for P4 and P 5, respectively.
Data Analysis

Data were analyzed using the Mixed procedure of the statistical
analysis system (SAS, 1996). Data were log transformed prior to analysis
to determine significance.

Means were separated by Fisher's least

significant difference test. Table values are reported as the least square
(LS) mean of the non-log transformed data with significance denoted at
P<0.05.
23

Table 1. Test for Parallelism of Pregnenolone Radio-Immunoassay

Sample
Pooled Media
(F1-F3 Follicles)

Volume Assayed
(µl)
35
45
55

Pregnenolone•
(ng/ml)
13.99 ± 0.42
13.63 ± 0.33
13.46± 1.07

•Mean ± standard error.

Table 2. Tests for Binding Efficiency of Pregnenolone Antiserum
Binding
Antibody Dilution•
(%)
50.01
1:18,000
48.29
1:20,000
45.50
1:23,000
42.83
1:25,000
38.06
1:28,000
*Final dilution according to the manufacturer's instructions (Accurate Scientific and
Chemical Corp., Westbury, NY).
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3.RESULTS

Production Characteristics

Hens from the LA line reached puberty (first egg) and 15% HDEP
earlier than did hens from the HA line (150 and 163 days of age versus 158
and 172 days of age, respectively).

Because of this difference in

reproductive age, LA hens were killed approximately 9 days prior to HA
hens during in vitro experiments in order to maintain differences due to
physiological age. Overall percent HDEP between the HA and LA lines
(66.62 and 63.47%, respectively) did not differ significantly (P>0.05).
However, if percent HDEP was measured from the day of first egg (day
150) to 442 days of age (cessation of the experiment), LA hens laid at a
higher rate (P<0.05), 64.53 versus 58.82%, respectively.
At both 16 and 37 weeks of egg production, ovary weight from HA
hens was greater (P<0.05) than that of LA hens (Table 3). In younger hens,
the size of F I and F3 follicles was not different between lines (P>0.05).
There was also no difference in either the number of small, slowly growing
(1-12 mm) or atretic follicles among hens from either genetic line (Table 4).
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Table 3. Ovary weight and size of F 1, F 2, and F 3 follicles for HA and LA
hens at 16 and 37 weeks of egg production*.
Weeks of Egg Production
II.

li
Follicle Weight,
Size, or Number
Ovary Weight
(grams)

F1 (mm:)
F2 (mm)
F3(mm)

Genetic Line/(number of hens)
HA/(n=20)
LA/(n=20)

42.49 ± 1.60 Bf
33.58 ± 0.33

8

29.97 ± 0.43 8
25.47 ± 0.61 AB

35.94 ± 1.56 C

Genetic Line/(number of hens)
HA/(n=20)
LA/(n=20)
47.80 ± 1.94 A
38.08± 1.60 BC

32.90 ± 0.33 B

35.19 ± 0.35 A

33.71 ± 0.33

28.50 ± 0.40 C
24.15 ± 0.58 BC

32.03 ± 0.45 A
26.47 ± 0.63 A

29.76 ± 0.41 8
23.18 ± 0.60 C

8

*Values are reported as least square means± standard error of the mean.

t A,B,CValues in the same row with different letters are significantly different (P :s; 0.05).
!Millimeters diameter.

Table 4. Numbers of 10 - 12 mm, 7- 9 mm, 4 - 6 mm, 1 - 3 mm, and atretic
follicles for HA and LA hens at 16 and 37 weeks of egg production*.
Weeks of Egg Production
II.

Number of Follicles
10 - 12 mm (No. t)
7-9 mm (No)
4-6 mm (No.)
1-3 mm (No.)
Atretic Follicles

16
Genetic Line/(number of hens)
LA/(n=20)
HA/(n=20)
l.21±0.17At
1.00 ± 0.17 A
4.00 ± 0.67A
5.30 ± 0.66 A
13.00 ± 1.07 AB
11.75 ± 1.04 8
8
25.80 ± 2.13 8
26.32 ± 2.19
4.32 ± 0.56 AB

4.05 ± 0.54 8

Genetic Line/(number of hens)
HA/(n=20)
LA/(n=20)
A
0.88 ± 0.17 A
1.06 ± 0.18
5.84 ± 0.67 A
5.88 ± 0.71 A
15.35 ± 1.13 A
11.16 ± 1.07 8
38.06 ± 2.31 A
28.47 ± 2.10 8

5.71 ± 0.59 A

*Values are reported as least square means± standard error of the mean.

t Number ofFollicles
;A,B,C Values in the same row with different letters are significantly different (P :s; 0.05).
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5.16 ± 0.56 AB

At 37 weeks of egg production, all pre-ovulatory follicles (F 1•3) were
larger (P<0.05) among HA hens as compared to LA hens. Similarly, there
were more (P<0.05) 1-3 and 4-6 mm small white follicles among older HA
hens, but not of 7-9 mm, 10-12 mm, or atretic follicles between lines.

In Vivo Steroid Secretion

Both plasma progesterone and luteinizing hormone were significantly
higher (P<0.05) among HA versus LA hens during the peak pre-ovulatory
period of the ovulatory cycle (Figures 1 and 2). Specifically, circulating
levels of progesterone (Figure 1) and luteinizing hormone (Figure 2) were
greater (P<0.05) among HA hens at 6, 5, 4, 3, 2, and 1 hours prior to
oviposition (Figure 1).

In Vitro Steroid Secretion

Similar to plasma levels, in vitro progesterone production was higher
(P<0.05) among HA hens as compared to LA hens. This was apparent in all
follicle sizes at both 16 and 37 weeks of egg production (Table 5).
Progesterone production by granulosa cells from both genetic lines was less
(P<0.05) at 37 weeks

of egg production,
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as compared to
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*Indicates significant difference (P,:::0.05).
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Figure 2. Plasma luteinizing hormone (ng/ml) during one ovulatory cycle in HA and LA hens
(combined data from samples collected at 14 and 35 weeks of egg production).
*Indicates significant difference (P::::0.05).

Table 5. In vitro progesterone and pregnenolone (P4 and PS; ng/ml)
secretion from granulosa cells of the 3 largest preovulatory follicles (F1,F2,
and F3) from HA and LA hens at 16 and 37 weeks of egg production.*
Weeks of Egg Production
1§
Genetic Line/(number of hens)

Steroid/Follicle
Size
P4(ng/ml)/
F1 follicle

F2 follicle
F3 follicle

P5 (ng/ml)/
F1 follicle
F2 follicle
F3 follicle

HA/{n=20}

LA/{n=20}

37
Genetic Line/(number ofhens)

HA/{n=20}

LA/{n=20}

242.35 ± 3.69 Atat

191.57 ± 3.35 Ab

189.89 ± 3.69 Be

147.52 ± 3.41 Bd

148.25 ± 2.08 Be
129.86 ± 1.53 Cb

141.24 ± 2.13 Bd
95.53 ± 1.55 Cc

271.75 ± 2.21 Aa
152.62 ± 1.46 Ca

164.86 ± 2.13 Ab
65.31 ± 1.53 Cd

12.51 ± 0.14 Aa
9.01 ± 0.10 Bd
6.30 + 0.08 Cc

12.24 ± 0.16 Bb
15.02 ± 0.11 Aa
10.90 + 0.08 Ca

9.92 ± 0.14 Ac
9.92 ± 0.10 Ac
6.07 + 0.08 Bd

12.70 ± 0.16 Aab
10.35 ± 0. 10 Bb
8.24 ± 0.08 Cb

*Values are reported as least square means± standard error of the mean. Significant differences
(P~0.05) are denoted by letter differences between the means oflog transformed data.
tA,B,CValues within the same column and for the same steroid with different letters are
significantly different (P~0.05).
t,b,c,dValues within the same row with different letters are significantly different (P~0.05).
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weeks of egg production. However, progesterone secretion was higher in F2
follicles among both lines at 37 weeks of age (P<0.05).
Similar differences were found in the production of pregnenolone by
granulosa cells of HA and LA hens (Table 5). Pregnenolone secretion by
granulosa cells was greater (P<0.05) among HA hens in all follicle sizes and
in both time periods with the exception that F 1 follicle secretion was the
same at 16 weeks of egg production. As would be expected, pregnenolone
production was less (P<0.05) among the smaller pre-ovulatory follicles (F 2
and F3) as compared to the F 1• However, as the hen aged, pregnenolone
secretion was found to remain the same (F 1 follicle in HA and LA hens;
P>0.05) or increase (F2 and F3 follicles in LA hens; P<0.05).

Steroid Secretion as Affected by TNFa.

In vitro treatment of granulosa cells with recombinant TNFa had

little effect on basal progesterone secretion. Treatment off 1 and F3 follicles
with hTNFa, but not mTNFa, resulted in a reduction (P<0.05) in
progesterone secretion (Table 6). This decrease was evident in F 1 follicles
among HA hens at 16 weeks of egg production and LA hens at 37 weeks of
egg production. Similarly, progesterone production was reduced (P<0.05)
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Table 6. In vitro progesterone (ng/ml) production from granulosa cells of
the Fi, F2, and F3 follicles in HA and LA hens at 16 and 37 weeks of egg
production in response to various treatments.
Weeks of Egg Production
16
Genetic Line/(number of hens)

37
Genetic Line/(number of hens)

Follicle Size/freatment
FI follicle/
Control (nothing)

HA/(n=20)

LA/(n=20)

HA/(n=20)

LA/(n=20)

123.65 c•at

90.46 Db

59.89 De

56.05 Cc

hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF

107.31 Da

96.54 CDa

61.58 Db

46.77 De
46.73 Dd

Pooled SEMl

F2 follicle/
Control (nothing)
hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEM
F3 follicle/
Control (nothing)
hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEM

121.78 Ca

100.51 Cb

330.57Ba

273.33 Bb

60.61 De
311.03 BCb

284.62 ABb

293.30 Cb

217.68 Be
224.34 Be

303.95 Ab
3.35

352.91 Ab
3.69

293.59 Ab
3.41

91.70 Cb

80.55 Cc

110.34 Da

79.12 De

89.93 Cb

78.81 Cc
81.24 Cc

104.83 Da

82.63 CDb

92.30 Cb

117.75Da

84.96 Cbc

188.82 Be

206.65 ABc
192.99 Be

378.78 Ca
431.72 Ba

238.29 Bb

194.33 Be
232.42 Ac
2.08

207.99 Ad
2.13

487.10 Aa
2.21

268.71 Ab
2.13

81.62 Ca

59.83 Bb

58.63 Cb

35.99Bc

80.31 Ca

55.58 Cb

56.64 Cb

33.22 Cc

82.19 Ca
171.04 Bb

54.84 Cc
127.20Ac

59.73 Cb
234.61 Ba

33.76 Cd
95.32 Ad

174.87 Bb

140.93 Ac
134.80 Ac
1.55

232.35 Ba

96.33 Ad

273.75 Aa
1.46

97.21 Ad
1.53

325.88Ba
444.89Aa
3.69

189.16 Ab
1.53

235.48 Bb

*A,B,C,DValues in the same column and for the same follicle size with different letters are significantly
different (P::::0.05).
t a,b,c,dValues in the same row with different letters are significantly different(P::::0.05).
tStandard error of the mean.
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in F 3 follicles among LA hens at both time periods. Human TNF a. had no
effect (P>0.05) on progesterone secretion from F2 granulosa cells,
regardless of genetic line or age.
Treatment of granulosa cells with oLH resulted in a large increase
(P<0.05) in progesterone secretion which was further increased (P<0.05)
after co-treatment with mTNFa. (Table 6), however this effect was lost in F3
LA follicles. Co-treatment of granulosa cells with hTNFa. and oLH did not
(P>0.05) result in an additive increase in progesterone secretion over that
observed with oLH alone.
As observed with progesterone secretion, in vitro pregnenolone
secretion declined in response to treatment with hTNFa., but not mTNFa.
(Table 7). This effect was more consistent among younger versus older
hens, HA versus LA hens, and in larger follicles (F 1 vs. F2 and F3).
Pregnenolone secretion was less (P<0.05) after exposure to h1NFa. in F 1
follicles among HA hens at 16 weeks of egg production, and LA hens at 37
weeks of egg production.

Similarly, less (P<0.05) pregnenolone was

produced by F2 granulosa cells from HA hens at both time periods, and F3
granulosa cells from both lines at 16 weeks of egg production in response to
treatment with hTNF a..
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Table 7. In vitro pregnenolone (ng/ml) production from granulosa cells of
the Fi,F2 , and F3 follicles in HA and LA hens at 16 and 37 weeks of egg
production in response to various treatments.
Weeks of Egg Production
1.§

Follicle Size/freatment
F1 follicle/
Control (nothing)
hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEMt
F2 follicle/
Control (nothing)
hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
PooledSEM

Genetic Line/(number of hens)
HA/(n=20)
LA/(n=20)
732 C*at

6.65 Cb

6.87Da
6.94 Da
17.11 Bb

37
Genetic Line/(number of hens)
HA/(n=20)
LA/(n=20)
6.22 CDb

5.48 Cc

5.89Db
6.40 Ca
18.30 Aba

4.53 De
5.15 Cb
13.73 Be
14.03 Bb
16.60 Ab
0.14

17.75 Ba

6.60 Ca
6.89 Ca
17.23 Bab
18.14 Aba

20.14 Aa
0.16

19.54 Aa
0.14

17.52 Ba
19.13 Aa
0.16

7.14 Cb
6.67 Db
7.00 CDb

5.79 Cd
5.50 Cd
5.55 Cd

7.95 Da
7.42 Ea
7.96 Da

13.27 Bb
13.60 ABb
14.45 Ab
0.10

12.09 Be
12.13 Be
12.98 Ac
0.10

20.79 Ca
21.93 Ba
24.07 Aa
0.11

6.34
6.16
6.19
13.47
13.21
14.16
0.10

Cc
Cc
Cc
Bb
Bb
Ab

F3 follicle/
4.11 Be
5.94 Ca
Control (nothing)
4.80 Bb
5.99 Ca
4.49 Cc
5.72 Ca
hTNF (5 ng/ml)
5.23 Db
4.05 Bd
4.17 Be
5.78 Ca
mTNF (5 ng/ml)
4.89 Bb
5.79 Ca
10.80 ABb
7.75 Ac
8.15 Ac
oLH (100 ng/ml)
15.18 Ba
8.07 Ac
7.81 Ac
oLH+hTNF
10.60 Bb
16.10 Aa
8.12
Ac
11.06
Ab
7.78
Ac
oLH+mTNF
16.61 Aa
0.08
0.08
PooledSEM
0.08
0.08
*A,B,C,DValues in the same column and for the same follicle size with different letters are significantly
different (P,:S0.05).
ta,b,c,dy alues in the same row with different letters are significantly different {P,:::0.05).
tStandard error of the mean.
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Similar to the effect on progesterone secretion, treatment of granulosa
cells with oLH resulted in a large increase (P<0.05) in pregnenolone
secretion (Table 7). Co-treatment of granulosa cells with mTNFa and oLH
caused a further increase (P<0.05) in pregnenolone secretion over that of
oLH alone in all preovulatory follicles.

This increase was predominant

among F 1 and F2 follicles, regardless of genetic line or age. F3 follicles
were basically unresponsive (P>0.05) to co-treatment with oLH and either
mouse or human TNFa. The significant increase (P<0.05) in pregnenolone
secretion due to oLH was not changed by addition of either form of the
cytokine.

Steroid Secretion as Affected by TNFa. During the Ovulatory Cycle
Fl follicles:

Analysis of data by time-point during the ovulatory cycle showed that
the effect of TNF a on basal progesterone secretion of granulosa cells from
young hens tended to occur very early (4 hrs) or very late (24 hrs) after
oviposition of the previous egg {Table 8).

The decline (P<0.05) in

progesterone secretion evident in HA hens (as described in Table 6) was
due to a reduction at 4 and 24 hours after oviposition. LA hens appeared to
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Table 8. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F 1 follicle at 4, 12,
18, and 24 hours after oviposition !11 HA_and LA hens at 16 weeks of egg production.
Genetic Line

LA

HA
Hours after Oviposition/(number of hens)

Steroidffreatment
Progesterone (ng/ml)/
Control (nothing)

w

0\

hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+ hTNF
oLH+mTNF
Pooled SEMt
Pregnenolone (ng/ml)/
Control (nothing)
hTNF (5 ng/ml)
mTNF (Sng/ml)
oLH (lOOng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEM

4/(n=S)

12/(n=S)

18/(n=S)

24/(n=5)

Hours after Oviposition/(number of hens)
4/(n=5)
12/(n=S)
18/(n=5)
24/(n=5)

138.10 c•at

147.03 Ca

161.94 Ca

47.55 Be

71.72 Bd

97.93 Bbc

108.99 Cb

83.17 Bed

114.63 Db
134.02 CDb

135.39 Ca

143.53 Ca

35.69 Cd

81.39 Be

88.07 Be

166.73 Ca

43.83 Be

75.80 Bd

89.85 Be
88.37 Be

126.84 BCab

142.52 Cab

327.00 Be

315.35 Be

564.96 Ba

114.98 Ae

135.79 Ae

303.89 Ac

318.33 Bb

361.90 Bb
49l.l2 Ab

506.78 Ba

116.50 Ad

136.80 Ad

334.51 Ab

442.85 Aa

224.31 Ac

693.32 Aa
6.70

136.47Ae

148.71 Ae
6.70

330.86 Ac

495.34 Ab
6.53

240.90 Ad
6.70

4.65 Ce

9.04 Bb

458.65 Ab
6.86

7.02

8.73

6.86

146.17 Bab

91.69 Be

444.22 Ab

209.42 Ad

6.90 Cc
6 _52 CDed

6.64 Cc

11.34 Ca

6.22 Cd

10.89 Ca

5.95 Dd

5.99 Cd

l l.60 Ca

14.33 Be

13.50 Be
13.75 Bed

31.42 Ba

9.19 Bd

11.l l Ad

13.35 Ac

22.69 Bb

9.34 Bb
21.76 Ab

31.l l Ba

10.86 Ae

l l.84 Ade

14.09 Ac

21.89 Bb

24.73 Ab

36.62 Aa
0.29

10.62 Ad
0.38

11.40 Ad

15.07 Ac
0.29

27.20 Ab
0.29

24.50 Ab
0.29

15.28 ABe
16.93 Ac
0.29

16.40 Ac
0.30

5.25 Bd

3.84 Cf

5.32 Cd
6.00 BCd

5.19 Be

6.99 Cc
7.31 Cbc

4.22 Cf

6.13 Bed

4.89 Be

7.19 Cc

0.29

*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P:s;0.05).
ta,b. · rValues in the same row with different letters are significantly different (P:s;0.05).
tStandard Error of the Mean.

7.91 Cb

be unresponsive to either form of TNFa..

The one exception was that

mTNFa. caused an increase (P<0.05) in progesterone secretion 18 hours
after oviposition.
The increased (P<0.05) progesterone production after co-treatment of
F 1 granulosa cells with mTNFa. and oLH was found to occur 4, 12, and 18
hours after oviposition in young HA hens {Table 8). LA hens were found to
be unresponsive to co-treatment with oLH and mTNFa.. Ovine LH induced
progesterone secretion from F 1 follicles of younger hens from each genetic
line was not affected by co-treatment with hTNFa..
Analysis of pregnenolone data obtained during the ovulatory cycle
showed that the hTNFa. induced decrease (P<0.05) occurred 4 hours after
oviposition in HA hens, and 4 and 24 hours after oviposition in LA hens
{Table 8).
The addition of mTNFa. (but not hTNFa.) plus oLH consistently
stimulated the production of pregnenolone by F 1 granulosa cells over that of
oLH alone, throughout the ovulatory cycle in younger hens from both lines
{Table 8). This was significant in HA hens at all times during the ovulatory
cycle, and in LA hens 18 hours after oviposition.
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Among older hens, the time response to TNFa was not observed in
either genetic line with few exceptions (Table 9). Progesterone secretion
increased (P<0.05) after exposure to hTh"'Fa in HA hens 12 hours after
oviposition. In LA hens, 24 hours after ovipostion, both forms of TNFa
reduced (P<0.05) F 1 follicle progesterone secretion.
As in younger hens, granulosa cells from F 1 follicles of older hens cotreated with mTNFa (but not hTNFa) and oLH consistently produced more
(P<0.05) progesterone throughout the ovulatory cycle than cells treated with
oLH alone (Table 9). Co-treatment resulted in higher (P<0.05) progesterone
secretion at 4 and 18 hours after oviposition in HA hens, and 4, 12, and 24
hours after ovipostion in LA hens.
Differences in pregnenolone production due to in vitro treatment of
F 1 granulosa cells in older hens with hTNFa appeared to be dependent on
genetic line (Table 9). While treatment with hTNFa suppressed (P<0.05)
pregnenolone production at all times during the ovulatory cycle in LA hens,
no effect (P>0.05) was seen in HA hens, regardless of time. As expected,
mouse TNFa had no effect {P>0.05) on the secretion of pregnenolone at any
time during the ovulatory cycle in either genetic line.
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Table 9. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F1 follicle at 4, 12,
18, and 24 hours after oviposition in HA and LA hens at 37 weeks of!_gg production.
Genetic Line

LA

HA
Steroidffreatment
Progesterone (ng/ml)/
Control (nothing)

v,J

\0

hTNF (S ng/ml)
mTNF (S ng/ml)
oLH (100 ng/ml)
oLH+ hTNF
oLH+mTNF
Pooled SEMt
Pregnenolone (ng/ml)/
Control (nothing)
hTNF (Sng/ml)
mTNF (Sng/ml)
oLH (l00ng/ml)
oLH+hTNF
oLH+mTNF

4/(n=S)

Hours after Oviposition/(number of hens)
18/(n=S)
24/(n=S)
12/(n=S)

Hours after Oviposition/(number of hens)
18/(n=S)
24/(n=S)
4/(n=S)
12/(n=S)

5239 C'bct

48.80 De

63.26 Cab

75.12Ba

37.91 Cd

60.38 Cb

56.33 Bbc

69.58 Cab

54.22 Cb
50.01 Cbc

57.99 Cb
61.29 Cab
638.54 ABa
586.28 Ba
735.94 Aa
6.53

73.58 Ba
73.01 Ba
309.57 Ab
265.23 Ab
291.97 Ac

38.44 Cc
37.09 Cd
232.45 Be
257.68 Bb
329.45 Abe
6.53

52.85 Cbc

128.94 Be
139.19 ABd
152.68 Ae
6.70

60.53 Cab
58.11 Cb
167.06 Bd
182.51 Be
231.06 Ad
7.02

50.49 Bbc
49.67 Bbc
157.77 Ad
149.55 Ad
141.90 Ae
6.70

45.29 De
46.88 De
179.74 Bd
211.04 Be
330.28 Abe
7.34

6.10 Cab
6.19 Ca
7.03 Ba
28.65 Aa
27.74 Aa
28.65 Aa
0.28

6.36 Cab
5.53 Cab
6.02 Cc
16.05 ABb
14.91 Bbc
16.84 Ab
0.29

8.98

6.23 Cab
5.87 Cab
5.93 Ced
17.03 ABb
15.45 Db
18.47 Ab
0.38

300.75 Bb
279.08 Bb
372.27 Ab
6.70

5.44 Bb
4.37 Cc
5.04 Bd
16.69 Ab
16.15 Ab
18.07 Ab
0.27
Pooled SEM
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P~0.05).
ta,b ... fValues in the same row with different letters are significantly different (P~0.05).
+Standard error of the mean.
6.21 Ba
5.96 Bab
6.61 Ba
11.48 Ac
11.98 Ac
12.58 Ac
0.29

4.57 Cc
3.85 De
4.86 Cd
15.74 Bb
15.87 Bb
18.63 Ab
0.29

53.26 Cbc

6.12 Bab
5.22 Cb
5 _60 BCcd
11.37 Ac
12.05 Ac
11.88 Ac
0.29

5.78 Cab

4.67 Dbc
5.09 CDd
11.llBc
12.04 Be
17.82 Ab
0.30

Pregnenolone production by F 1 granulosa cells was further increased
(P<0.05) over that of oLH alone in response to co-treatment with m1NFa in
LA, but not HA, hens at 37 weeks of egg production (Table 9).
Specifically, these cells secreted more (P<0.05) pregnenolone 4 and 24
hours after ovipostion.

F2follicles:

Basal production of progesterone by F2 granulosa cells measured at 4,
12, 18, or 24 hours after oviposition was unaffected (P>0.05) by treatment
with either form of TNFa with one exception(Tables 10 and 11 ). As with
F 1 follicles, F2 progesterone secretion was less (P<0.05) 4 hours after
oviposition among older HA hens in response to hTNFa.
In vitro treatment of F2 follicles with mTNFa and oLH consistently

resulted in higher (P<0.05) progesterone secretion as compared to treatment
with oLH alone among hens of both genetic lines and at either age (Tables
10 and 11). This was most evident in HA versus LA hens (Table 10).
Basal pregnenolone secretion was only reduced (P<0.05) after
treatment with hTNFa 12 hours after oviposition in either genetic line at 16
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Table 10. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F2 follicle at 4,
12, 18, and 24 hours after oviposition in HA and LA hens at 16 weeks_of egg production.
Genetic Line

LA

HA

Hours after Oviposition/(number of hens)
Steroidffreatment
Progesterone (ng/ml)/
Control (nothing)

....
.I:>,

hTNF (S ng/ml)
mTNF (S ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEMt
Pregnenolone (ng/ml)/
Control (nothing)
hTNF (S ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEM

Hours after Oviposition/(number of hens)

4/(n=S)

12/(n=S)

18/(n=S)

24/(n=S)

4/(n=S)

12/(n=S)

18/(n=S)

24/(n=S)

97.84 C*bt
98.26 Cc
100.22 Cb
192.93 Be
197.09 Be
239.79 Abe
4.21

100.17 Cb

131.20 Ca

37.59 Ce

49.78 Cd

95.77 Bb

117.71 Ba

58.93 Be

100.49 Cbc
101.30 Cb
195.66 Be
222.25 ABbc
245.60 Ab
4.21

122.92 Ca
129.41 Ca
273.05 Bb
253.74 Bb
329.46 Aa
4.00

38.05 Ce
38.26 Cd
93.61 Be
104.26 ABd
114.82 Ae
4.21

50.60 Cd
52.69 Cc
123.37 Bd
112.23 Bd
141.45 Ad
4.32

98.60 Bbc
91.62 Bb
186.59 Ac
203.09 Ac
209.29 Ac
4.42

114.20 Bab
126.64 Ba
400.53 Aa
343.14 Aa
373.53 Aa
4.32

51.83 Bd
54.01 Be
116.08 Ad
110.42 Ad
07.71 Ae
4.00

5.85 CDd
6.97 Be
9.71 Ba
4.99 Be
3.91 Bf
6.90 Cc
5.80 Ced
9.65 Ba
4.91 Bd
4.29 Be
6.33 Cc
5.36 Dd
_
BCbc
6 51
6.73 Cbc
5.14 Bd
9.61 Ba
4.25 Be
6.07 Cc
9.16 Ae
12.67 Bed
11.76 Ad
19.48Aa
9.99 Ac
13.64 Be
9.98 Ad
12.56 Be
12.82 Ac
19.02 Aa
13.65 Be
10.80 Ad
9.93 Ade
14.03 Abe
13.02 Ac
11.45 Ad
20.82 Aa
15.75 Ab
0.20
0.22
0.20
0.21
0.19
0.21
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P!>0.05).
t3,b ... rValues in the same row with different letters are significantly different (P!>0.05).
tStandard error of the mean.

8.41 Bb

7.25 Cb
7.25 Cb
16.36 Ab
15.92 Ab
15.60 Ab
0.21

5.00 Ce
5.11 Cd
4.63 Cd
8.37 ABe
8.14 Be
9.13 Ae
0.20

Table 11. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F2 follicle at 4,
12, 18, and 24 hours after oviposition in HA and LA hens at 37 weeks of egg production.
Genetic Line
Steroidffreatment
Progesterone (ng/ml)/
Control (nothing)

~

N

hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEMt
Pregnenolone (ng/ml)/
Control (nothing)
hTNF (5 ng/ml)
mTNF (5ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEM

HA
Hours after Oviposition/(number of hens)
12/(n=S)
4/(n=S)
18/(n=S)
24/(n=S)
7630 c•cdt

197.71 Da

98.03 Cb

65.08 Dd
74.49 CDd
226.99 Bd
256.29 ABcd
275.45 Acd
4.32

187.56 Da
214.96 Da
679.54 Ca
830.86 Ba
969.65 Aa
4.61

97.19 Cb
106.91 Che
179.05 Be
230.20 Ad
233.79 Ae
4.42

5.85 Be
5.59 Be
6.IOBd
17.07 Ac
17.08 Ac
17.05Acd
0.21

I 0.47 Ba
9.82 Ba
10.78 Ba
31.02 Aa
31.81 Aa
34.65 Aa
0.21

8.82 Cb

LA
Hours after Oviposition/(number of hens)
4/(n=S)
12/(n=5)
18/(n=S)
24/(n=S)

69.35 Bd

40.00 Ce

79.85 Cc

104.51 Bb

92.13 Bb

69.49 Bd
74.66 Bd
429.52 Ab
409.53 Ab
469.51 Ab
4.32

48.68 Ce
48.03 Ce
146.15 Bf
158.31 Be
206.16Ae
4.32

80.91 Cc
87.81 Cc
258.79 Bd
279.30 ABc
311.26 Ac
4.32

103.33 Bb
109.72 Bb
312.79 Ac
277.68 Ac
313.14 Ac
4.21

97.61 Bb
94.26 Be
235.42 Ad
226.64 Ad
244.26 Ad
4.21

6.65 Ced
6.10 Cc
6.52 Cd
20.99 Bb
22.30 Bb
26.34 Ab
0.22

4.43 Bf
6.45 Cd
8.18 Cb
4.67 Bd
5.94 Cc
8.46 Cb
4.38 Be
6.08 Cd
!3.2 I Bde
14.lOBd
11.72 Ae
16.54 Acd
13.69 Bde
11.64 Ae
18.24 Ac
11.78 Af
15.63 Ad
0.21
0.22
0.22
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P:':0.05).
ta,b ... fValues in the same row with different letters are significantly different (Ps0.05).
tStandard error of the mean.

7.40 Be
7.96 Bb
7.54 Bbc
15.87 Ac
15.07 Ad
15.92 Ad
0.20

7.07 Bed
6.08 Cc
6 _77 Bed
13.06 Ade
12.44 Ae
13.31 Ae
0.20

weeks of egg production {Tables 10 and 11). As before, mTNFa had no
effect (P>0.05) on basal secretion ofpregnenolone.
Co-treatment of F2 granulosa cells with a combination of either
mTNFa or hTNFa and oLH did not increase (P>0.05) F2 follicle
pregnenolone production from hens of either genetic line with few
exceptions {Tables 10 and 11). Pregnenolone secretion was higher (P<0.05)
among younger HA hens 4 hours after ovipostion, and 18 and 24 hours after
oviposition in older HA hens after in vitro treatment with mTNFa and oLH.
In LA hens of both ages, pregnenolone production increased (P<0.05) 12
hours after oviposition in response to co-treatment with mTNFa plus LH.

F3 follicles:

Only isolated effects on F3 follicle progesterone production were
observed due to treatment with hTNFa {Tables 12 and 13).

Reduced

(P<0.05) progesterone production was observed in HA hens 4 hours after
oviposition at both 16 and 37 weeks of egg production.

F3 follicle

progesterone secretion was less (P<0.05) among LA hens 4 hours after
oviposition at 16 weeks of egg production, and 18 hours after oviposition at
both ages. Treatment ofF 3 follicles from younger LA hens with mTNFa
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Table 12. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of F3 follicles at 4, 12,
18, and 24 hours after oviposition in HA and LA hens at 16 weeks of llgg production.
Genetic Line
Steroidffreatment
Progesterone (ng/ml)/
Control (nothing)

.J::.J::-

hTNF (S ng/ml)
mTNF (S ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEMt

HA
Hours after Oviposition/(number of hens)
4/(n=S)
12/(n=S)
18/(n=S)
24/(n=S)

78.61 C*ct
67.45 Dd
72 _20 CDcd
195.86 Bb
218.37 ABa
242.67 Aa
2.89

86.34 Cbe
93.64 Cb
90.30 Cb
206.02 Bb
207.72 Ba
235.67 Aa
2.82

LA
Hours after Oviposition/(number of hens)
4/(n=S)
12/(n=S)
18/(n=S)
24/(n=S)

127.08 Ba

34.45 CDe

37.26 Be

56.48 Cd

92.98 Cb

52.58 Bd

123.07 Ba
135.95 Ba
242.95 Aa
230.66 Aa
229.97 Aa
3.17

37.08 Cf
30.31 Df
39.32 Bf
42.74 ABe
48.32 Ae
3.30

31.88 Cg
30.99 Cf
117.61 Ad
121.27 Ac
125.05 Ac
2.82

59.84 BCd
64.39 Bd
143.51 Ac
148.44 Ab
154.60 Ab
2.89

78.30 De
77.62 De
156.47 Be
204.18 Aa
171.08 Bb
3.66

52.30 BCe
46.36 Ce
91.21 Ae
89.80 Ad
88.46 Ad
2.96

Pregnenolone (ng/ml)
Control (nothing)
5.4 8 Cbc
5.27 Be
4.39 Cd
8.60 Ba
4.92 Bed
3.86 Be
4.66 Ced
hTNF (Sng/ml)
4.84 De
3.47 De
7.96 Ba
3.23 Ce
4.23 Cd
mTNF (S ng/ml)
5.27 CDc
5.52 Be
8.54 Ba
4.29 Bde
3.80 De
4.62 BCd
10.42 Bbc
oLH (100 ng/ml)
11.55 Ab
16.00 Aa
5.25 Ag
7.11 Be
8.00 Ad
oLH+hTNF
11.39 Ab
11.38 ABb
4.41 Be
15.21 Aa
8.07 Ac
7.78 Ac
oLH+mTNF
11.76 Ab
12.24 Ab
15.22 Aa
6.92 Bde
7.36 Ad
5.01 Af
Pooled SEM
0.15
0.16
0.16
0.19
0.15
0.15
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (Ps;0.05).
ta,b ... gValues in the same row with different letters are significantly different (PS:0.05).
tStandard error of the mean.

5.97 Cb
6 .40 BCb
6.68 Db
9.65 Ac
10.42 Ab
10.42Ac
0.19

4.45 Bd
4.10 BCd
3.98 Ce
6.24 Af
6.01 Ad
6.41 Ae
0.15

Table 13. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of F3 follicles at 4, 12,
18 and 24 hours after oviposition in HA and LA hens at 37 weeks of egg production.
Genetic Line
Steroidffreatment
Progesterone (ng/ml)/
Control (nothing)

~

Vl

hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEMt
Pregnenolone (ng/ml)/
Control (nothing)
hTNF (5 ng/ml)
mTNF (5 ng/ml)
oLH (100 ng/ml)
oLH+hTNF
oLH+mTNF
Pooled SEM

HA
Hours after Oviposition/(number of hens)
4/(n=5)
12/(n=5)
24/(n=5)
18/(n=5)
54 _72 C*bct
44.98 De
48.37 De
182.79 Bb
162.18 Be
210.78 Ab
2.89

5.40cc
5.38 Cb
5.34 Cbc
12.40 Bb
13.15 Be
14.68 Ab
0.15

LA
Hours after Oviposition/(number of hens)
4/(n=5)
12/(n=5)
18/(n=5)
24/(n=5)

71.20 Da

57.40 Be

57.18 Cbc

12.50 Be

60.59 Bb

33.88 Bd

70.85 Da
80.24 Ca
325.81 Ba
300.25 Bb
366.86 Aa
2.75

54.28 Bb
57.24 Bb
98.22 Ad
99.73 Ac
107.47 Ad
3.03

56.45 Cb
53.05 Cbc
331.60 Ba
362.25 Ba
409.90 Aa
2.96

11.44 Bf
12.00 Be
50.62 Ae
54.33 Af
51.98 Af
2.82

53.95 Bb
56.85 Bb
115.58Ac
114.22 Ad
127.98 Ac
3.30

28.23 Ce
32.72 Bd
102.62 Acd
91.65 Ae
94.78 Ae
3.17

5.13 Be
5.51 Bb
5.39 Bbc
9 .40 Acd

4.56 Cd
3.96 De
4.28 CDc
8.64 Ad
7.52 Bf
8.01 ABd
0.17

6.86 Ba
6.69 Ba
7.44 Ba
19.78Aa
19.21 Ab
20.42 Aa
0.15

5.68 Cbc
5.25 Cb
5.51 Cb
9.96 ABc
10.16Ad
9.16 Be
0.16

6.01 Cb
5.56 Cb
4.87 De
18.57 Ba
21.87 Aa
22.19 Aa
0.16

2.53 CDe
2.42 Dd
2.78 Cd
6.46 Ae
5.94 ABg
5.67 Be
0.15

9.16 Ade
9.95 Ac
0.19

*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P::;0.05).
ta,b gValues in the same row with different letters are significantly different (P::;0.05).
tStandard error of the mean.

37.00 BCd
39.27 Bd
33.46 Cd
112.46 Ac
125.12 Ad
114.llAcd
2.89

4.23 Bd
4.32 Be
4.22 Be
8.10 Ad
8.61 Ae
8.87 Ac
0.15

reduced (P<0.05) progesterone secretion 4, 18, and 24 hours after
oviposition.
Co-treatment of F3 granulosa cells with mTNFa and oLH increased
(P<0.05) progesterone production over that observed with oLH alone from
HA, but not LA, hens as the ovulatory cycle progressed (Tables 12 and 13).
This was evident at 4, 12, and 24 hours after oviposition in HA hens,
regardless of age.
The decrease m F3 pregnenolone secretion after treatment with
hTNFa was primarily a result of lowered (P<0.05) steroid production in
younger hens at 4, 12, and 24 hours after oviposition in HA hens, and 4 and
12 hours after oviposition among LA hens (Tables 12 and 13). In older
hens, this response to hTNFa was diminished and observed only in the LA
line 18 hours after oviposition.

Treatment of F3 granulosa cells with

mTNFa caused reduced (P<0.05) pregnenolone secretion 24 hours after
oviposition among both lines at 16 weeks of egg production, and at the
same time in HA hens at 37 weeks of egg production.
The limited effect on pregnenolone secretion after co-treatment with
mTNFa and oLH was found to occur early in the ovulatory cycle, and
primarily in HA hens (Tables 12 and 13). Pregnenolone production in HA,
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but not LA, hens increased (P<0.05) at 12 hours after oviposition in younger
hens, and at 4 and 24 hours after oviposition in older hens. Interestingly,
mTNFa and oLH caused a reduction (P<0.05) in pregnenolone production
by F3 granulosa cells from older LA hens 4 hours after oviposition. This
was the only case in which the mTNFa and oLH treatment caused a
decrease in either steroid (regardless of follicle size, age, or genetic line).
Treatment of F3 granulosa cells with hTNFa and oLH decreased (P<0.05)
pregnenolone secretion at 24 hours after oviposition in younger HA hens,
and at 18 hours after oviposition in older LA hens.
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4. DISCUSSION

As reported previously, Single Comb White Leghorn hens, selected
for their ability to respond to an immune challenge with SRBC's, are
known to differ in fertility, growth rate, age at puberty, egg production, and
ability to resist bacterial or viral infection (Hall et al., 1978; Gross et al.,
1980; Siegel and Gross, 1980; Siegel et al., 1982; Martin et al., 1990;
Dunnington et al., 1991). Siegel et al. (1982) and Bryan et al. (1997)
reported that LA hens reached puberty before HA hens ( 13 and 14 days
respectively), and laid more (P<0.05) eggs to 300 days of age. In the
current study, overall percent HDEP did not differ between genetic lines.
However, both the date of puberty and 15% HDEP in hens of the LA line
occurred 9 days prior to that of HA hens. Consequently, when percent
HDEP to 442 days of age was measured, it was found that LA hens
produced more (P<0.05) eggs than HA hens.

Dunnington and Siegel

( 1984) suggested that LA hens began to lay before HA hens simply because
they attained the body weight necessary for reproduction at an earlier age.
Serial sampling of blood plasma revealed that levels of circulating
progesterone and luteinizing hormone were higher (P<0.05) among HA
hens from the time of the preovulatory surge until ovulation. Given the
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previously described differences between HA and LA hens, there may also
exist a divergence in the levels and/or activities of certain enzymes within
the steroid pathway. If these differences do exist, they could influence the
production of steroids to the extent that the rate of egg production may be
affected. Currently, the reason(s) for the differing levels of progesterone
and luteinizing hormone between these genetic lines is unknown.
At both 16 and 3 7 weeks of egg production, the ovary from HA hens
weighed more (P<0.05) than that of LA hens. In older hens, this difference
may be explained by the presence of larger (P<0.05) preovulatory follicles
(F 1-F 3) and a greater (P<0.05) number of small, 1-6 mm follicles on the
ovary. In younger hens, however, an explanation was not as forthcoming.
At 16 weeks of egg production, only F2 follicles were larger (P<0.05) in
HA hens. There were no differences in the numbers of 1-12 mm follicles
among HA and LA hens at 16 weeks of egg production. So, some factor
other than tissue weight is contributory to the higher steroid production
associated with HA hens.
The conversion of pregnenolone to androgens occurs via one of two
different pathways.

The Li5 pathway involves the metabolism of

pregnenolone to androstenedione (At) using dihydroepiandrostenedione
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(DHEA) as an intermediary, while in the ~ 4 pathway, pregnenolone is
converted to Ai through progesterone (Lee et al., 1998; Figure 3). A recent
study showed that, although both avian granulosa and theca cells have
functional ~ 4 and ~ 5 pathways, granulosa cells prefer the ~ 4 pathway,
whereas theca cell steroidogenesis occurs mainly via the ~5 pathway (Lee et

al., 1998). As the F I follicle matures, its ability to convert progesterone to
androstenedione diminishes, due to a decrease in the activity of the P450
17a.-hydroxylase/17,20 lyase enzyme complex (Robison and Etches, 1986).
This inability of ovarian cells from the F I follicle to convert progesterone to

Figure 3. The fl.4 and fl.5 steroidogenic pathways* t
*CHOL: cholesterol; P 5: pregnenolone; P4: progesterone; DHEA: dihydroepiandrosterone; ~: androstenedione;
T2 : testosterone; E2 : estradiol-l 7P; P450scc: cholesterol side-chain cleavage enzyme; 3P-HSD: 3Phydroxysteroid dehydrogenase; P450cl 7: cytochrome P450 17a.-hydroxylase/l 7,20 lyase; P450arom: aromatase.
tThis figure taken from Lee et al. ( 1998); Domestic Animal Endocrinology, 15: 1-8.
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androstenedione leads to an accumulation of the former. Progesterone
released from granulosa cells in the hen activates receptors present in the
hypothalamus and anterior pituitary, inducing the release of LH
(Kawashima et al., 1979).

Luteinizing hormone, in turn, binds to

receptors on the granulosa cells of preovulatory follicles, causing them to
secrete more progesterone. This positive feedback loop culminates in
preovulatory "spikes" (or peaks) of progesterone and LH that occur
approximately 6 hours prior to ovulation (Wilson and Sharp, 1973;
Johnson and van Tienhoven, 1980).

Therefore, it is possible that a

decrease in progesterone could interfere with this positive feedback cycle,
and ultimately delay or inhibit ovulation.
The production of progesterone by granulosa cells increases as
follicles mature. It is clear that much of the progesterone produced by
granulosa cells from F 2 and F 3 follicles diffuses to the theca layer and is
further metabolized to androgens or estrogen (Etches and Duke, 1984).
Progesterone produced by F 1 follicle granulosa cells however is subject to
no further modification, and is released into the peripheral circulation
(Etches and Duke, 1984). In the current study, in vitro progesterone and
pregnenolone production was higher among more mature preovulatory
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follicles (F 1>F 2>F3). However, at 37 weeks of egg production, F2 follicles
produced more progesterone and pregnenolone than did F 1 follicles. This
unexpected difference in steroid production may have resulted from the
inadvertent addition of higher cell numbers to culture media. Analysis of
total media protein did not explain differences in steroid secretion because
of the relatively high amount of BSA added to the culture media as
compared to total protein secreted by granulosa cells in the 3 hour
incubation period.
In the mammal, the effects ofTNFa. on ovarian steroidogenesis have
been researched in detail. TNF a. has been shown to inhibit FSH induced
steroid production, aromatase activity, and LH receptor number in
undifferentiated granulosa cells of the rat (Emoto and Baird, 1988; Adashi

et al., 1989; Darbon et al., 1989). Given these observations, it is possible
that the cumulus phenotype (i.e. low aromatase, reduced LH binding, and
decreased steroidogenic potential) is caused by ovarian TNFa in mammals,
and tends to "spare" the follicle from premature differentiation. Terranova
( 1997) suggested that one function of TNF a. may be to protect the
undifferentiated oocyte from the adverse effects associated with estrogen.
Butcher et al. (1975) reported that delayed ovulation, which is associated
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with prolonged exposure to estrogen, increased abnormalities in oocytes.
More over, FSH driven estrogen production and LH receptor formation are
of critical importance if granulosa cells are to differentiate (Darbon et al.,
1989). Therefore, TNFa may be involved in the inhibition of this process
in mammals.
In mammalian granulosa cells that are undergoing or have undergone
differentiation to luteal cells, the effects of 1NFa appear to be somewhat
different. 1NFa has been shown to reduce LH stimulated progesterone
production in the rat, pig, and cow, while stimulating the production of
PGF 2a (Velhuis et al., 1991; Benyo and Pate, 1992; Adashi et al., 1990;
Branstromm et al., 1993; Pitzel et al., 1993). Therefore, it appears that
1NFa may participate to some extent in luteal regression (Terranova et al.,
1995).
There is very little information available concerning the effect of
cytokines on ovarian steroidogenesis in the avian. Bryan et al. ( 1997)
reported that in vitro progesterone was consistently reduced (P<0.05)
below basal levels when granulosa cells from domestic hens were treated
with a dose of 5 ng/ml h1NFa.
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In this study, treatment of granulosa cells with human 1NFa
decreased (p<0.05) basal progesterone production in F 1 and F3 follicles,
and confirmed the report of Bryan et al. (1997).

Similarly, basal

pregnenolone secretion from all preovulatory follicles was reduced
(P<0.05) in response to treatment with hlNFa. However, in most cases,
preovulatory follicles appeared unresponsive to mouse TNFa, with few
effects observed on basal progesterone and pregnenolone secretion.
Johnson and van Tienhoven (1984) demonstrated a dose-dependent
decrease of in vivo progesterone levels in response to injection with
aminoglutethimide (a potent inhibitor of steroidogenesis). This reduction
in progesterone resulted in the absence of either an LH surge or ovulation.
The reintroduction (via injection) of progesterone resulted in a renewed
preovulatory surge of LH, followed by ovulation of the F 1 follicle. While
this is proof that a reduction in progesterone can inhibit ovulation, the
threshold at which progesterone must fall below for this to occur is
unknown.
In order to determine the point during the ovulatory cycle when
1NFa was affecting steroid secretion, a time-course study was conducted.
Although hTNFa consistently caused a numerical reduction in basal
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progesterone and pregnenolone secretion by granulosa cells, these
differences were rarely significant (P<0.05). The lack of significance
observed in the time-course study may have been due to small sample size
(5 hens/time-point).

As a result, no clear pattern emerged as to when

specifically hTNFa was having its affect.
It is well known that LH stimulates the production of progesterone
from granulosa cells in the domestic hen (Hammond et al., 1980; Marrone
and Hertelendy, 1983). Asem et al. (1983) determined that progesterone
production by granulosa cells increased when cultured in the presence of
ovine LH. In the current research, treatment of granulosa cells with oLH
stimulated (P<0.05) progesterone production over basal levels without
exception.
In contrast to the effects ofhTNFa on basal progesterone production
during the ovulatory cycle, there was indeed a clear and well defined
response of granulosa cells when treated with mTNFa, but not hTNFa, in
the presence of an ovulatory amount of oLH (100 ng/ml). Under these
circumstances, the secretion of progesterone and pregnenolone increased
(over that produced in response to treatment with oLH alone) among hens
of both ages and genetic lines, in all follicle sizes, and at almost all times
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during the ovulatory cycle. Co-treatment of granulosa cells with hTNFa
and

oLH did,

occasionally,

increase

(P<0.05)

progesterone and

pregnenolone secretion over that of oLH alone. However, this was not as
consistent as that observed after treatment with oLH and the murine form
of TNFa. Branstrom et al. (1995) reported that co-treatment of perfused
rat ovaries with hTNFa (40 ng/ml) and oLH (100 ng/ml) increased in vitro
progesterone production as compared to treatment with oLH alone.
Furthermore, they reported a four-fold increase in the rate of LH induced
ovulatory rates when perfused ovaries were exposed to hTNFa. At this
time, the significance of an increase in progesterone productions by
granulosa cells in the hen is not known. Zolti et al. (1990) found that
concentrations of TNFa in bovine follicular fluid increased as ovulation
approached.

This implies the possibility that, in the hen, TNFa may

potentiate the LH induced production of progesterone as follicles mature,
and thereby augment or at least influence the ovulatory process.
Recently, Tartaglia and Goedde! (1992) proposed a model by which
the 75 kDa type II receptor for TNF a could sequester TNF a and "pass it
on" to the 55 kDa type I receptor. As discussed previously, the type II
receptor has a greater affinity for TNFa than does the type I receptor.
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However, TNFa. dissociates from the type II receptor at a greater rate than
from the type I receptor, thereby facilitating interaction of the cytokine
with the type I receptor (Medvedev et al., 1996). Since the type II receptor
does not associate with human TNFa., this effect would only be observed
when studying the murine form. Corroborating evidence for this "ligand
passing" model comes from a study in which hTNFa. was considerably less
effective than mTNFa in the induction of IL-6 in vitro and in vivo in the
mouse (Benigni et al., 1996).

However, when the authors injected

antibodies to each receptor, they found that activation of the type I receptor
was more effective in stimulating the production of IL-6.

In fact, it

appeared that the antibody to the type II receptor was absolutely incapable
of inducing IL-6 production (Benigni et al, 1996). Recently, the type I
receptor for TNFa has been implicated in the induction of HIV-1
expression (Matsuyama et al., 1991 ). Butera et al. ( 1996) found no direct
action of HIV-1 by the type II receptor.

However, when the type II

receptor was blocked (by antibodies), the effect of TNFa. on HIV-I
induction was decreased markedly, suggesting to the authors that the type
II receptor enhanced the binding of TNFa. to the type I receptor. There
exists the possibility that this "ligand passing" model is applicable to the
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increased in vitro production of progesterone by granulosa cells of the hen
in response to m1NFa. and oLH. It should not, however, be ruled out that
the effects ofm1NFa. and oLH on steroidogenesis in the laying hen are the
result of a direct activation of the type II 1NFa. receptor.
Future research should be aimed at the identification and
localization, as well as the physiologic roles, of the 1NFa. receptors in the
ovary of the laying hen. Finally, since these studies utilized only granulosa
cells, it would be of great interest to study the effect(s) of 1NFa. on the
intact follicle composed of theca and granulosa cells.
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5. SUMMARY

Single Comb White Leghorn hens, genetically selected for either high
or low levels of antibody in response to an immune challenge with SRBC's,
displayed different production characteristics. Low antibody hens reached
sexual maturity approximately 9 days before HA hens, and laid more
(P<0.05) eggs to 442 days of age. Analysis of in vivo steroid production
showed that

both progesterone and luteinizing hormone were higher

(P<0.05) among HA hens during the 6 hours prior to ovulation. Although
the reason( s) for these differences are currently unknown, they may be due
to differences in the levels or activities of enzymes within the steroid
pathway or differential tissue response to either gonadotropins or steroids.

In vitro progesterone and pregnenolone production was generally
higher (P<0.05) among HA hens as compared to LA hens, and in larger
versus smaller preovulatory follicles. As in the mammal, TNFa appears to
inhibit basal steroidogenesis in the laying hen. Treatment of granulosa cells
with hTNFa, but not mTNFa resulted in reduced (P::::::0.05) progesterone and
pregnenolone production. However, these decreases were not as prevalent,
or of the magnitude of those previously reported by our laboratory (Bryan et
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al., 1997). Conversely, in vitro treatment of granulosa cells with mTNFa in

the presence of an ovulatory amount of oLH (100 ng/ml) consistently and
markedly

increased

(P<0.05)

the

secretion

of progesterone

and

pregnenolone over that observed after treatment with either oLH alone or
hTNFa and oLH.
The observation that co-treatment of granulosa cells with mTNFa and
oLH stimulated steroid secretion over that produced in response to
treatment with hTNFa and oLH suggests a role for the type II TNFa
receptor in potentiating the effects of the type I TNFa receptor. However,
since the intracellular domains of the two receptors share little or no
sequence homology, it is unclear whether these differences in steroid
production are the result of ligand passing, or a direct activation of the type
II receptor.
Due to the high incidence of exposure to microbial pathogens in
commercial poultry operations, the study of the effects of cytokines on
avian reproduction is of great importance. A better understanding of how
these cytokines influence the reproductive cycle in the avian will allow for
appropriate responses to infection, as well as, reinforce the need for
preventative measures.
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